Instead of tweaking the diagnostic criteria for MS in those with CIS,we should develop diagnostic criteria that distinguish MS from other conditions – No
Restricted accessOtherFirst published online May, 2019
Instead of tweaking the diagnostic criteria for MS in those with CIS,we should develop diagnostic criteria that distinguish MS from other conditions – No
BrownleeWJHardyTAFazekasFet al. Diagnosis of multiple sclerosis: Progress and challenges. Lancet2017; 389(10076): 1336–1346.
2.
TintoreMRoviraARioJet al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain2015; 138(Pt. 7): 1863–1874.
3.
ThompsonAJBanwellBLBarkhofFet al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
4.
Van der Vuurst de VriesRMMescheriakovaJYWongYYMet al. Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome. JAMA Neurol2018; 75(11): 1392–1398.
5.
BrownleeWJMiszkielKATurCet al. Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology2018; 91(12): e1130–e1134.
6.
SolomonAJBourdetteDNCrossAHet al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology2016; 87(13): 1393–1399.
7.
CorteseRMagnollayLTurCet al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology2018; 90(14): e1183–e1190.
8.
AbsintaMRoccaMAColomboBet al. Patients with migraine do not have MRI-visible cortical lesions. J Neurol2012; 259: 2695–2698.
9.
BrownleeWJSwantonJKAltmannDRet al. Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. J Neurol Neurosurg Psychiatry2015; 86(5): 584–585.